Influence of Particle Size and Patient Dosing Technique on Lung Deposition of HFA-Beclomethasone from a Metered Dose Inhaler
Authors:
- 1 December 2005
- journal article
- research article
- Published by SAGE Publications in Journal of Aerosol Medicine
- Vol. 18 (4) , 379-385
Abstract
The objective of this study was to determine the lung delivery of HFA-134a-beclomethasone dipropionate (HFA-BDP) from a breath-activated inhaler (QVAR™ Autohaler™) compared with proper and improper press and breathe (QVAR™ P&B) metered dose inhaler (MDI) technique. The hypothesis was that that the smaller particles of BDP from HFA-BDP would stay suspended longer in the inspiratory air of patients and thus reduce the deleterious effects of inhaler discoordination. The study was an open label, four period, cross-over design. Asthmatic patients (n = 7) with a history of asthma symptoms, an FEV-1 of >70% of predicted normal, and a history of reversibility to a beta-agonist of ≥12% were utilized. BDP was radiolabeled with technetium-99m and delivered from the QVAR Autohaler or QVAR P&B device in patients trained to reproducibly utilize coordinated and discoordinated P&B MDI technique. Patients using Autohaler MDI exhibited 60% lung deposition of BDP. Patients using coordinated technique with the P&B MDI exhibited 59% lung deposition. Patients trained to consistently actuate the P&B MDI before inhaling exhibited 37% lung deposition. Patients trained to consistently actuate the P&B MDI late in the inspiration (i.e., 1.5 sec into a 3-sec inspiration) exhibited 50% lung deposition. In conclusion, the breath-activated Autohaler automatically provided optimal BDP lung deposition of 60%. Patients with good P&B MDI technique also received optimal lung deposition of 59%. The degree of lung deposition was decreased as patients demonstrated poor inhaler technique. However patients with poor technique still received a large lung dose of BDP (i.e., ≥37%) compared with lung deposition values of 4–7% for CFC-BDP MDIs previously published and confirmed in this study.Keywords
This publication has 10 references indexed in Scilit:
- Lung Deposition of Hydrofluoroalkane-134a Beclomethasone Is Greater Than That of Chlorofluorocarbon Fluticasone and Chlorofluorocarbon BeclomethasoneChest, 2002
- A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalersInternational Journal of Pharmaceutics, 1999
- Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasoneEuropean Respiratory Journal, 1998
- A Comparison of Breath-Actuated and Conventional Metered-Dose Inhaler Inhalation Techniques in Elderly SubjectsChest, 1993
- The adult patient’s difficulties with inhalersLung, 1990
- Use and Misuse of Metered-dose Inhalers by Patients with Chronic Lung Disease: A Controlled, Randomized Trial of Two Instruction MethodsAmerican Review of Respiratory Disease, 1989
- Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern.Thorax, 1988
- New Method for Easy Labeling of Beta-2-Agonists in the Metered Dose Inhaler with Technetium 99 mRespiration, 1988
- Deposition of pressurised aerosols in the human respiratory tract.Thorax, 1981
- The adequacy of inhalation of aerosol from canister nebulizersThe American Journal of Medicine, 1980